Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 2

1(16.7%)

6Total

N/A(5)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07126756Not ApplicableActive Not Recruiting

LASIK iDesign vs SMILE

Role: collaborator

NCT05611814Not ApplicableCompleted

Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms

Role: lead

NCT04155333Not ApplicableCompleted

Effects of Non-Invasive Brain Stimulation on Soldiers' Cognitive and Functional Performance

Role: lead

NCT04697901Not ApplicableCompleted

Sustaining Aviator Performance During Extended Operational Flight

Role: lead

NCT03893032Phase 2Unknown

Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants

Role: lead

NCT02829073Not ApplicableUnknown

Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study

Role: lead

All 6 trials loaded